Biotech Blueprint is a newsletter and a podcast where biotech professionals and industry insiders come together to unpack the trends, challenges, and breakthroughs shaping the future of biotech. In our first episode, I sat down with Hartaj Singh, veteran biotech analyst and founder of Biotech Capital Compass, for a candid conversation about career pivots, the rise of mRNA cancer vaccines, AI in drug discovery, and what recent layoffs in the public and private sectors signal for the industry's next chapter. We also dive into how we each curate biotech news, why community matters, and what it means to build a life and career in this ever-evolving space. This is just the beginning of a series aimed at honest, thoughtful discussions with those moving biotech forward.